Podbit · Huberman Lab
After loss, the brain's prediction circuits don't shut off — they keep firing, expecting the person to be in familiar locations, to call at their usual times, to respond to messages. This 'reverberatory activity' is the neurological engine of yearning, and it explains why grief feels so physically disorienting.
Where this was said
At 10:30 · chapter starts 9:20
The most viscerally relatable section of the episode opens here. Huberman explains that the brain's deep catalog of episodic memories — every conscious recollection of a shared moment — isn't erased by loss. These memories are interwoven with predictions: the brain continually generates expectations about where a person will be and when they will make contact, based on years of learned patterns. When that person is gone, the prediction engine doesn't receive a software update — it keeps running. [1] — Andrew Huberman "The brain continues to make these predictions that they will be in a certain place or a certain time. All of those predictions still hold. …" 10:37 The result is what Huberman calls reverberatory activity: circuits continuing to fire, producing the impulse to text them, the reflex to glance at the door when they'd normally come home, the phantom ring of a phone call that will never come. This is not weakness or psychological dysfunction — it is the normal operation of a brain whose spatial-temporal-emotional map has been violently disrupted. Understanding this transforms the experience from 'why can't I get over this?' into 'of course my brain is doing this.'
Social norms compress behavior so effectively that we assume other minds are similar to ours. They almost never are. After running over 100 psychology studies, Greenberg's biggest finding is that humans are far more different from each other than we intuitively believe.
The widely shared claim that we have a credit card's worth of plastic in our brains may be a massive overestimate. Researchers used nitrile gloves to measure microplastics — and nitrile gloves shed microplastic particles onto the measuring device. A second paper found the original tool used was unreliable, and that we may have far less plastic than reported.
RSD isn't just hurt feelings — it's a dopamine-deficient brain with a hyperactive amygdala and a frayed connection to the prefrontal cortex. Add a surge of norepinephrine and you get chest pain, sweating, and trembling that convinces your body something catastrophic is happening.
In Dan Ariely's door experiment, participants sacrificed the highest-reward door — repeatedly — just to avoid seeing other doors disappear. Even when researchers trained them to use the best door, they kept wasting clicks to maintain options. This is the bias that runs our lives: we'll take a worse outcome to preserve the feeling of optionality.
Dan Gilbert discovered that the brain has a 'psychological immune system' — it misremembers, reframes, and rationalizes to keep you satisfied with whatever you chose. The fear before commitment is all about potential regret. But after committing, your brain quietly starts justifying the choice — and the more irreversible the decision, the stronger the effect.
The psychological immune system can get you through the first few months of any commitment. But durable, long-term well-being requires self-concordance — choosing commitments that are genuinely aligned with your values and what you actually want. Without that alignment, the satisfaction fades fast.
Vision didn't just help animals find food — it ignited the Cambrian explosion of speciation. Half of the human cortex is devoted to visual processing, and that same visual hierarchy directly inspired the neural network architectures powering today's AI.
Peptides come loaded with a powerful narrative: regenerative, subcutaneous, targeted, cutting-edge. That narrative can genuinely move outcomes, especially for pain, energy, and recovery. The RCT's job is to quantify how much additional benefit comes from the molecule itself — above and beyond the compelling story surrounding it.
A pharmaceutical is not an amino acid sequence — it is the successful solution to manufacturing, purification, formulation, and consistency challenges. When clinical trials prove a drug works, they validate a specific product under specific processes, not every preparation that shares the same sequence.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.